Re: Pfizer to Acquire Medivation (Enzalutamide) for $14 B

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

chicagoest

Rank: President [?]

Points: 1974 [?]

Votes: 20 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Pfizer to Acquire Medivation (Enzalutamide) for $14 B

in response to

Pfizer to Acquire Medivation (Enzalutamide) for $14 B

BearDownAZ

posted on Aug 22, 2016 09:30PM

BDAZ

I first saw this Pfizer acquisition notice in a post on the SH board.

Following are links to Zenith slides regarding the ZEN-3694 trial.

http://78449.choruscall.com/dataconf/productusers/zenith/presentations/zenith20160620_v2/superhighres_slides/Slide12.JPG

http://78449.choruscall.com/dataconf/productusers/zenith/presentations/zenith20160620_v2/superhighres_slides/Slide13.JPG

http://78449.choruscall.com/dataconf/productusers/zenith/presentations/zenith20160620_v2/superhighres_slides/Slide14.JPG

Very Interesting

Chicagoest

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply